Back to News
Market Impact: 0.2
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Source: zacks.com
Analyst EstimatesMarket Technicals & Flows
Haemonetics was a big mover in the previous session on higher-than-average trading volume. The article says the latest earnings-estimate revision trend may make it harder for the stock to continue rising in the near term; it provides no price change or revision figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
HAE-0.20
More News
- Verizon stock heads for worst day since 2002 as SpaceX U.S. network plans whack telcos
- French yields are near levels not seen since 2002. Why that could give U.S. Treasurys a boost
- What's behind the recovery rally in tech stocks — plus, Elon Musk's very good week
- SpaceX’s Wireless Threat Rises With Spectrum Deal
- Pilot killed in attacks by Iran-backed Houthis on Riyadh airport; Saudi-led coalition vows 'firm' response
- OpenAI's revenue scare, Delta earnings, what investors think of a Starbucks-Chipotle deal and more in Morning Squawk